Qumis | $2,200,000 | (Jan 22, 2025)
Zynap | $5,937,902 | (Jan 22, 2025)
Belfry | $12,000,000 | (Jan 22, 2025)
Certified by Founder
Lodge
OverT Bio
start up
United States
- New York, NY
- 07/05/2024
- Seed
- $16,000,000
Finding new genes to power transformative cell therapies.
- Industry Biotechnology Research
- Website https://www.overt.bio/home
- LinkedIn https://www.linkedin.com/company/overt-bio/
Related People
Mat LegutCo Founder
United States -
New York, New York
My scientific interests focus on developing T-cell immunotherapies for hard-to-treat solid tumors.
Gravity(US) | $13,000,000 | (Jan 22, 2025)
LeapXpert | $20,000,000 | (Jan 22, 2025)
BPR Hub | $2,600,000 | (Jan 22, 2025)
NovoLINC | Undisclosed Amount | (Jan 22, 2025)
IntusCare | $11,500,000 | (Jan 21, 2025)
ecoplanet | $16,571,680 | (Jan 21, 2025)
Sereact | $25,894,660 | (Jan 21, 2025)
Fundment | $55,157,175 | (Jan 21, 2025)
Men In Blazers Media Network | $150,000,000 | (Jan 21, 2025)